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Abstract 
Cervical cancer is the most common gynecological cancer and one of the major causes of 
female cancer-related death worldwide particularly in developing countries. Thus far, there 
are a few in vivo models have been developed in investigating this type of cancer. In this 
study, we induced cervical cancer in Balb/c mice by exploiting the carcinogenic property of 
diestylstilbestrol (DES). The Balb/c pregnant mice were given subcutaneous (SC) injection of 
67 μg/kg body weight of DES on GD 13, and the mice gave birth approximately at gestation 
day 19-22. Female offspring were reared and the body weight was recorded once weekly. The 
female offspring were sacrificed at age of 5 months. Upon termination, blood was collected 
in a plain tube via cardiac puncture and the reproductive tracts were collected and weighed. 
The reproductive tract sections were stained using H&E for observation of pathological 
changes. The progression of disease state was monitored by measuring the level of serum 
interleukin (IL-6) using the Mouse IL-6 ELISA Assay Kit (BD OptEIA™, USA). All 
parameters were compared with Not-induced group. The outcome of this study demonstrated 
a significant difference in body weight gain, reproductive organ weight, diameter of cervix 
and the level of serum IL-6 in the Induced group as compared to the Not-induced group (P< 
0.05). Histopathological findings revealed the presence of adenosis only in the Induced 
group. It shows that DES could be employed as an agent to induce cervical carcinogenesis in 
animal model. In addition to that, new potential anti-cancer agents from various sources 
could be further evaluated using this technique. 
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